<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39129538</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2047-2986</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2024</Year><Month>Aug</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of global health</Title><ISOAbbreviation>J Glob Health</ISOAbbreviation></Journal><ArticleTitle>Excess risks of long COVID symptoms compared with identical symptoms in the general population: A systematic review and meta-analysis of studies with control groups.</ArticleTitle><Pagination><StartPage>05022</StartPage><MedlinePgn>05022</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">05022</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7189/jogh.14.05022</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">It is important to understand the excess risks of symptoms of long COVID when compared to the same symptoms in the general population. We aimed to evaluate the association between coronavirus disease 2019 (COVID-19) infection and various long-term symptoms.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We conducted a systematic review and meta-analysis of studies measuring long COVID symptoms lasting for at least three months after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in comparison to non-COVID-19 control groups. We searched MEDLINE and Embase (via Ovid), CINAHL (via EBSCOhost), the ProQuest Coronavirus Research Database, and the World Health Organization COVID-19 Research Database for relevant literature on 14 February 2023. The symptom list had 10 categories with 29 symptoms, including general, neurologic, respiratory, cardiac, dermatologic, eye, ear, musculoskeletal, psychiatric, and gastrointestinal symptoms. We performed random-effects meta-analysis and summarised the results using odds ratios (OR) and 95% confidence intervals (CI), after which we conducted subgroup analyses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We included 51 studies with 17&#x2009;901&#x2009;204 participants (range of mean age: 5.9-65.4 years; range of proportion of women: 11.2-96.0%). In the primary analysis, participants with COVID-19 had a significantly higher risk of having at least one long COVID symptom (OR&#x2009;=&#x2009;2.032; 95% CI&#x2009;=&#x2009;1.787-2.310). Specifically, they had higher risks of 25 symptoms, the highest of which were for smell (OR&#x2009;=&#x2009;8.474; 95% CI&#x2009;=&#x2009;6.357-11.295), taste (OR&#x2009;=&#x2009;5.881; 95% CI&#x2009;=&#x2009;3.818-9.059), post-exertional malaise (OR&#x2009;=&#x2009;3.187; 95% CI&#x2009;=&#x2009;2.602-3.904), shortness of breath (OR&#x2009;=&#x2009;2.497; 95% CI&#x2009;=&#x2009;2.125-2.935), brain fog (OR&#x2009;=&#x2009;2.093; 95% CI&#x2009;=&#x2009;1.362-3.218), hair loss (OR&#x2009;=&#x2009;2.082; 95% CI&#x2009;=&#x2009;1.291-3.358), chest pain (OR&#x2009;=&#x2009;2.056; 95% CI&#x2009;=&#x2009;1.692-2.498), cognitive decline (OR&#x2009;=&#x2009;1.992; 95% CI&#x2009;=&#x2009;1.560-2.544), palpitations (OR&#x2009;=&#x2009;1.986; 95% CI&#x2009;=&#x2009;1.647-2.395), and fatigue (OR&#x2009;=&#x2009;1.971; 95% CI&#x2009;=&#x2009;1.781-2.182). We found significant differences between studies with different follow-up times in cognitive decline, dizziness, palpitations, and sleep problems (P&#x2009;&lt;&#x2009;0.05). Adults had significantly higher risks of cognitive decline, hair loss, and joint pain than children (P&#x2009;&lt;&#x2009;0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">We found that COVID-19 can significantly increase the risk of many long COVID symptoms, without differences due to gender, age, or decrease over time after three months post-infection. This highlights that services and interventions for long COVID symptoms are needed.</AbstractText><AbstractText Label="REGISTRATION" NlmCategory="UNASSIGNED">PROSPERO (CRD42023409847).</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 by the Journal of Global Health. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zijun</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wenyue</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Dexing</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Tam</LastName><ForeName>King Wa</ForeName><Initials>KW</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yiqi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Dicken Cheong Chun</ForeName><Initials>DCC</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zuyao</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Samuel Yeung Shan</ForeName><Initials>SYS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Scotland</Country><MedlineTA>J Glob Health</MedlineTA><NlmUniqueID>101578780</NlmUniqueID><ISSNLinking>2047-2978</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosure of interest: The authors completed the ICMJE Disclosure of Interest Form (available upon request from the corresponding author) and disclose no relevant interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>12</Day><Hour>4</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39129538</ArticleId><ArticleId IdType="pmc">PMC11317913</ArticleId><ArticleId IdType="doi">10.7189/jogh.14.05022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO Coronavirus (COVID-19) Dashboard. 2023. Available: https://covid19.who.int/. Accessed: 22 September 2023.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence; 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Post COVID-19 condition (Long COVID). 2022. Available: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition#:~:text=It%20is%20defined%20as%20the,months%20with%20no%20other%20explanation. Accessed: 22 September 2023.</Citation></Reference><Reference><Citation>Wu Q.Understanding the burden of post-covid-19 condition. BMJ. 2023;381:p932. 10.1136/bmj.p932</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.p932</ArticleId><ArticleId IdType="pubmed">37257892</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh BB, Devleesschauwer B, Khatkar MS, Lowerison M, Singh B, Dhand NK, et al. Disability-adjusted life years (DALYs) due to the direct health impact of COVID-19 in India, 2020. Sci Rep. 2022;12:2454. 10.1038/s41598-022-06505-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-06505-z</ArticleId><ArticleId IdType="pmc">PMC8844028</ArticleId><ArticleId IdType="pubmed">35165362</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahriani M, Ilmawan M, Fajar JK, Maliga HA, Frediansyah A, Masyeni S, et al. Persistence of long COVID symptoms in COVID-19 survivors worldwide and its potential pathogenesis-a systematic review and meta-analysis. Narra J. 2021;1:e36. 10.52225/narraj.v1i2.36</Citation><ArticleIdList><ArticleId IdType="doi">10.52225/narraj.v1i2.36</ArticleId><ArticleId IdType="pmc">PMC10914031</ArticleId><ArticleId IdType="pubmed">38449463</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A.Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899. 10.1016/j.eclinm.2021.100899</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28:657&#x2013;66. 10.1016/j.cmi.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A.Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens. 2022;11:269. 10.3390/pathogens11020269</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood SA, Shafran R, Bennett S, Zhang AX, O&#x2019;Mahoney LL, Stephenson TJ, et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies. J Infect. 2022;84:158&#x2013;70. 10.1016/j.jinf.2021.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. 10.1136/bmj.n160</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n160</ArticleId><ArticleId IdType="pmc">PMC8005925</ArticleId><ArticleId IdType="pubmed">33781993</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall IJ, Marshall R, Wallace BC, Brassey J, Thomas J.Rapid reviews may produce different results to systematic reviews: a meta-epidemiological study. J Clin Epidemiol. 2019;109:30&#x2013;41. 10.1016/j.jclinepi.2018.12.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2018.12.015</ArticleId><ArticleId IdType="pmc">PMC6524137</ArticleId><ArticleId IdType="pubmed">30590190</ArticleId></ArticleIdList></Reference><Reference><Citation>Beets MW, Weaver RG, Ioannidis JPA, Pfledderer CD, Jones A, von Klinggraeff L, et al. Influence of pilot and small trials in meta-analyses of behavioral interventions: a meta-epidemiological study. Syst Rev. 2023;12:21. 10.1186/s13643-023-02184-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-023-02184-7</ArticleId><ArticleId IdType="pmc">PMC9938611</ArticleId><ArticleId IdType="pubmed">36803891</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329:1934&#x2013;46. 10.1001/jama.2023.8823</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahmy O, Fahmy UA, Alhakamy NA, Khairul-Asri MG.Single-port versus multiple-port robot-assisted radical prostatectomy: a systematic review and meta-analysis. J Clin Med. 2021;10:5723. 10.3390/jcm10245723</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245723</ArticleId><ArticleId IdType="pmc">PMC8703720</ArticleId><ArticleId IdType="pubmed">34945018</ArticleId></ArticleIdList></Reference><Reference><Citation>Losilla J-M, Oliveras I, Marin-Garcia JA, Vives J.Three risk of bias tools lead to opposite conclusions in observational research synthesis. J Clin Epidemiol. 2018;101:61&#x2013;72. 10.1016/j.jclinepi.2018.05.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2018.05.021</ArticleId><ArticleId IdType="pubmed">29864541</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner RM, Davey J, Clarke MJ, Thompson SG, Higgins JP.Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol. 2012;41:818&#x2013;27. 10.1093/ije/dys041</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys041</ArticleId><ArticleId IdType="pmc">PMC3396310</ArticleId><ArticleId IdType="pubmed">22461129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huedo-Medina TB, S&#xe1;nchez-Meca J, Mar&#xed;n-Mart&#xed;nez F, Botella J.Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11:193. 10.1037/1082-989X.11.2.193</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/1082-989X.11.2.193</ArticleId><ArticleId IdType="pubmed">16784338</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Smith GD, Schneider M, Minder C.Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;34. 10.1136/bmj.315.7109.629</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;rensen AIV, Spiliopoulos L, Bager P, Nielsen NM, Hansen JV, Koch A, et al. A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark. Nat Commun. 2022;13:4213. 10.1038/s41467-022-31897-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31897-x</ArticleId><ArticleId IdType="pmc">PMC9302226</ArticleId><ArticleId IdType="pubmed">35864108</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiliopoulos L, S&#xf8;rensen AIV, Bager P, Nielsen NM, Vinsl&#xf8;v Hansen J, Koch A, et al. Post-acute symptoms four months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study. Am J Epidemiol. 2024;193:1106&#x2013;1114. 10.1093/aje/kwad225</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwad225</ArticleId><ArticleId IdType="pmc">PMC11299024</ArticleId><ArticleId IdType="pubmed">37981717</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q, Jia M, Sun Y, Jiang B, Cui D, Feng L, et al. One-Year Temporal Changes in Long COVID Prevalence and Characteristics: A Systematic Review and Meta-Analysis. Value Health. 2023;26:934&#x2013;42. 10.1016/j.jval.2022.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2022.11.011</ArticleId><ArticleId IdType="pubmed">36436792</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudgal SK, Gaur R, Rulaniya S, Latha T, Agarwal R, Kumar S, et al. Pooled prevalence of long COVID-19 symptoms at 12 months and above follow-up period: a systematic review and meta-analysis. Cureus. 2023;15:e36325. 10.7759/cureus.36325</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.36325</ArticleId><ArticleId IdType="pmc">PMC10108372</ArticleId><ArticleId IdType="pubmed">37077615</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762. 10.1016/j.eclinm.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T, Menges D, Anagnostopoulos A, Domenghino A, Aschmann HE, Frei A, et al. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study. BMJ. 2023;381:e074425. 10.1136/bmj-2022-074425</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-074425</ArticleId><ArticleId IdType="pmc">PMC10230608</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk Factors Associated With Post&#x2212;COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern Med. 2023;183:566&#x2013;80. 10.1001/jamainternmed.2023.0750</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Z, Giuriato M.Demographic And Clinical Factors Associated With Long COVID. Health Aff (Millwood). 2023;42:433&#x2013;42. 10.1377/hlthaff.2022.00991</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2022.00991</ArticleId><ArticleId IdType="pubmed">36877912</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld MS, Peluso MJ, Peyser ND, Lin F, Knight SJ, Djibo A, et al. Factors Associated With Long COVID Symptoms in an Online Cohort Study. Open Forum Infect Dis. 2023;10:ofad047. 10.1093/ofid/ofad047</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad047</ArticleId><ArticleId IdType="pmc">PMC9945931</ArticleId><ArticleId IdType="pubmed">36846611</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28:1706&#x2013;14. 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Coronavirus disease (COVID-19). 2023. Available: https://www.who.int/news-room/fact-sheets/detail/coronavirus-disease-(covid-19). Accessed: 11 October 2023.</Citation></Reference><Reference><Citation>Peeples L.Understanding Kids and COVID. Proc Natl Acad Sci U S A. 2022;119:e2203753119. 10.1073/pnas.2203753119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2203753119</ArticleId><ArticleId IdType="pmc">PMC9060488</ArticleId><ArticleId IdType="pubmed">35316141</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ.Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;46. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Julg B, Mohandas S, Bradfute SB, Force RMPT.Viral persistence, reactivation, and mechanisms of long COVID. eLife. 2023;12:e86015. 10.7554/eLife.86015</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R, Banerjee A, Baker MR, Dani M, Ford E, Hull JH, et al. Long COVID: mechanisms, risk factors and recovery. Exp Physiol. 2023;108:12&#x2013;27. 10.1113/EP090802</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP090802</ArticleId><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C, et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022;54:1473&#x2013;87. 10.1080/07853890.2022.2076901</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogale KA, Zeru T, Tarkegn M, Balew M, Worku M, Asrat A, et al. Awareness and care seeking for long COVID symptoms among Coronavirus disease survivors in Bahir Dar City, Northwest Ethiopia: phenomenological study. BMC Public Health. 2023;23:941. 10.1186/s12889-023-15889-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-15889-0</ArticleId><ArticleId IdType="pmc">PMC10206544</ArticleId><ArticleId IdType="pubmed">37226170</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper E, Lound A, Atchison CJ, Whitaker M, Eccles C, Cooke GS, et al. Awareness and perceptions of Long COVID among people in the REACT programme: Early insights from a pilot interview study. PLoS One. 2023;18:e0280943. 10.1371/journal.pone.0280943</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0280943</ArticleId><ArticleId IdType="pmc">PMC9879384</ArticleId><ArticleId IdType="pubmed">36701357</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaatz M, Springer S, Schubert R, Zieger M.Representation of long COVID syndrome in the awareness of the population is revealed by Google Trends analysis. Brain Behav Immun Health. 2022;22:100455. 10.1016/j.bbih.2022.100455</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100455</ArticleId><ArticleId IdType="pmc">PMC8957367</ArticleId><ArticleId IdType="pubmed">35373158</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Scotland Knowledge Services. Long COVID bulletin. 2024. Available: https://knowledgescotnhs.libguides.com/currentawareness/longcovid. Accessed: 11 October 2023.</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ.Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;46. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. New survey results show health systems starting to recover from pandemic. 2023. Available: https://www.who.int/news/item/02-05-2023-new-survey-results-show-health-systems-starting-to-recover-from-pandemic. Accessed: 11 October 2023.</Citation></Reference><Reference><Citation>European Commission. Long COVID activities and results in the EU and the US Background document for the 13 December 2022 EU-US Long COVID conference. 2023. Available: https://health.ec.europa.eu/system/files/2022-12/ncd_20221213_background_en.pdf. Accessed: 11 October 2023.</Citation></Reference><Reference><Citation>Department of Health and Human Services. Implementing and Evaluating New Models for Delivering Comprehensive, Coordinated, Person-Centered Care to People with Long COVID (U18). 2023. Available: https://grants.nih.gov/grants/guide/rfa-files/RFA-HS-23-012.html. Accessed: 11 October 2023.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Long COVID or Post-COVID Conditions. 2023. Available: https://www.cdc.gov/covid/long-term-effects/index.html. Accessed: 9 October 2023.</Citation></Reference><Reference><Citation>Ceban F, Kulzhabayeva D, Rodrigues NB, Di Vincenzo JD, Gill H, Subramaniapillai M, et al. COVID-19 Vaccination for the Prevention and Treatment of Long COVID: A Systematic Review and Meta-analysis. Brain Behav Immun. 2023;111:211&#x2013;29. 10.1016/j.bbi.2023.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.03.022</ArticleId><ArticleId IdType="pmc">PMC10067136</ArticleId><ArticleId IdType="pubmed">36990297</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022;53:101624. 10.1016/j.eclinm.2022.101624</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Agency of Canada. Evidence brief on the associations and safety of COVID-19 vaccination and post COVID-19 condition. Canda: Public Health Agency of Canada; 2022. Available: https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/canadas-reponse/summaries-recent-evidence/evidence-brief-associations-safety-covid-19-vaccination-post-condition.html. Accessed: 11 October 2023.</Citation></Reference><Reference><Citation>Harrison S, Walters B, Simmons Z, Cook M, Clark R. The effectiveness of vaccination against long COVID: A rapid evidence briefing. London, UK: UK Health Security Agency; 2022. Available: https://assets.publishing.service.gov.uk/media/65020e0097d3960014482e47/The-effectiveness-of-vaccination-against-long-COVID-a-rapid-evidence-briefing.pdf. Accessed: 11 October 2023.</Citation></Reference><Reference><Citation>Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P.Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2023;2:e000385. 10.1136/bmjmed-2022-000385</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Gavaghan D, Egger M.Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53:1119&#x2013;29. 10.1016/S0895-4356(00)00242-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-4356(00)00242-0</ArticleId><ArticleId IdType="pubmed">11106885</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>